Ophtec Unfazed By FDA Panel Limitations On Phakic IOL Patient Group

Ophtec expects FDA to approve its Artisan phakic intraocular lens in the next six months with less restrictive labeling than recommended by the Ophthalmic Devices Panel Feb. 5

More from Archive

More from Medtech Insight